FWM
EBS icon

FSA Wealth Management’s Emergent Biosolutions EBS Stock Holding History

FSA Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150
Closed -$9K – 394
2020
Q1 		$9K Buy
+150
New +$8.64K 0.01% 252

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FSA Wealth Management's EBS Position: Q2 2020 in Review

FSA Wealth Management sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 150 shares — an estimated $9K sold.

FSA Wealth Management first reported a position in EBS in Q1 2020 and held it in 1 quarter. The position peaked at $9K in Q1 2020. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • FSA Wealth Management reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • FSA Wealth Management sold 150 Emergent Biosolutions shares in Q2 2020, an estimated $9K.
  • FSA Wealth Management first reported a position in Emergent Biosolutions in Q1 2020 and held it in 1 quarter.
  • FSA Wealth Management's Emergent Biosolutions position peaked at $9K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on FSA Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.